Pulmonary Sarcoidosis: Clinical Trials

5 trials for Pulmonary Sarcoidosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 unknown. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 2, Terminated 2, Unknown 1
Phase 21Terminated 1

Follow Pulmonary Sarcoidosis: new trials by email Literature Review of Pulmonary Sarcoidosis trials Research Report on Pulmonary Sarcoidosis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Efzofitimod 3 mg/kg, Efzofitimod 5 mg/kg, Placebo - Pulmonary Sarcoidosis
Phase 3CompletedaTyr Pharma, Inc.2682022-09-152026-06-04
Randomized Controlled Trial of Hydroxychloroquine Combined With Low-dose Corticosteroid in Pulmonary Sarcoidosis
Hydroxychloroquine + low-dose prednisone, Prednisone - Pulmonary Sarcoidosis
Phase 3UnknownAssistance Publique - Hôpitaux de Paris2002022-03-012022-02-21
Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis
Methionine, DOTANOC - Pulmonary Sarcoidosis
Phase 2 / Phase 3TerminatedTurku University Hospital52016-05-012026-10-07
Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS).
Prednisone, Hydroxychloroquine + Prednisone - Pulmonary Sarcoidosis
Phase 3CompletedUniversity of Milano Bicocca942009-03-012014-07-25
Mycophenolate for Pulmonary Sarcoidosis
Mycophenolate - Pulmonary Sarcoidosis
Phase 3TerminatedMedical University of South Carolina202003-09-012018-06-18

Narrower conditions

Sarcoidosis, Pulmonary (5)  ·  Sarcoidosis (3)  ·  Fibrosis (1)  ·  Granuloma (1)  ·  Inflammation (1)  ·  Lung Diseases, Interstitial (1)  ·  Lymphoproliferative Disorders (1)

Broader conditions

Hemic and Lymphatic Diseases (5)  ·  Hypersensitivity (5)  ·  Hypersensitivity, Delayed (5)  ·  Immune System Diseases (5)  ·  Lung Diseases (5)  ·  Lymphatic Diseases (5)  ·  Respiratory Tract Diseases (5)  ·  Lung Diseases, Interstitial (4)  ·  Lymphoproliferative Disorders (4)  ·  Sarcoidosis (2)  ·  Immunoproliferative Disorders (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Hydroxychloroquine (2)  ·  Prednisone (2)  ·  68Ga-DOTANOC (1)  ·  Methionine (1)  ·  Mycophenolic Acid (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Medical University of South Carolina (1)  ·  Turku University Hospital (1)  ·  University of Milano Bicocca (1)  ·  aTyr Pharma, Inc. (1)

Countries

Italy (2)  ·  United States (2)  ·  Brazil (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Alberto Pesci (1)  ·  Don C Rockey, MD (1)  ·  Juhani Knuuti, MD, PhD (1)  ·  Lisa Carey (1)  ·  Marc A Judson, MD (1)

Results publications

PMID 37902990